ACHE and early-onset autosomal dominant Alzheimer disease: The impact of structural bioinformatics on AChE pharmacology is not limited to Alzheimer’s disease but has also extended to other biomedical applications, such as the development of antidotes against neurotoxins and organophosphate pesticides.